Hao-Wen Kao

Title: Hao-Wen Kao: Innovator in Radiolabeled Active Targeting Pharmaceutical Composition

Introduction

Hao-Wen Kao is a prominent inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of radiolabeled active targeting. With a total of 3 patents to his name, his work is paving the way for advancements in tumor therapy.

Latest Patents

One of Hao-Wen Kao's latest patents is focused on a radiolabeled active targeting pharmaceutical composition. This innovative composition includes a bioconjugate and a radionuclide. The bioconjugate consists of a biomolecule and a metal nanoparticle, where the biomolecule has an affinity for receptors on the surface of a cell membrane. It is selected from a group that includes peptides and proteins. The invention also provides a method for evaluating thermal adjuvant therapy for tumors, along with a kit for this purpose. The pharmaceutical composition is designed to evaluate tumor accumulation time, which helps establish the optimal policy for radiofrequency- or laser-induced thermal adjuvant therapy for tumors.

Career Highlights

Hao-Wen Kao has worked with notable organizations such as the Institute of Nuclear Energy Research and the Atomic Energy Council under the Executive Yuan. He has also been associated with National Yang Ming Chiao Tung University, where he has contributed to research and development in his field.

Collaborations

Some of his notable coworkers include Hsin-Ell Wang and Wuu-Jyh Lin, who have collaborated with him on various projects.

Conclusion

Hao-Wen Kao's innovative work in radiolabeled active targeting pharmaceutical compositions showcases his dedication to advancing medical therapies. His contributions are significant in the ongoing efforts to improve treatment options for tumors.